Related Experiment Video
Updated: Jun 21, 2026

Investigating the Effects of Probiotics on Pneumococcal Colonization Using an In Vitro Adherence Assay
Published on: April 28, 2014
Probiotic effects on cold and influenza-like symptom incidence and duration in children
Gregory J Leyer1, Shuguang Li, Mohamed E Mubasher
1Department of Research and Development, Danisco, Madison, Wisconsin, USA. greg.leyer@danisco.com
Insights
Daily probiotic supplements significantly reduced cold and flu symptoms in young children. This included fewer instances and shorter durations of fever, cough, and runny nose, leading to fewer missed school days.
Area of Science:
- Pediatric Health
- Microbiology
- Immunology
Background:
- Common respiratory infections significantly impact young children's health and school attendance.
- Probiotics, live microorganisms conferring a health benefit, are explored for their potential to modulate the immune system and reduce infection risk.
Purpose of the Study:
- To evaluate the efficacy of specific probiotic strains, Lactobacillus acidophilus NCFM and Bifidobacterium animalis subsp lactis Bi-07, in reducing the incidence and duration of cold and influenza-like symptoms in healthy children aged 3-5 years.
- To assess the impact of probiotic supplementation on antibiotic use and school absenteeism.
Main Methods:
- A 6-month, double-blind, placebo-controlled study involving 326 children aged 3-5 years.
- Participants were randomized to receive a placebo, single-strain probiotic (L. acidophilus NCFM), or a combination probiotic (L. acidophilus NCFM + B. animalis subsp lactis Bi-07) twice daily.
Main Results:
- Probiotic groups showed significant reductions in fever incidence (53.0%-72.7%) and duration (32%-48%) compared to placebo.
- Significant decreases in cough incidence (41.4%-62.1%) and duration were observed. Rhinorrhea incidence was reduced, particularly in the combination group (58.8%).
- Antibiotic use decreased by 68.4%-84.2%, and missed group child care days were reduced by 27.7%-31.8% in probiotic groups.
Conclusions:
- Daily probiotic supplementation with L. acidophilus NCFM and/or B. animalis subsp lactis Bi-07 is safe and effective for reducing respiratory illness symptoms in young children.
- Probiotic use led to decreased antibiotic prescriptions and fewer school absences, highlighting their potential role in pediatric preventive health.
Objective:
Probiotic consumption effects on cold and influenza-like symptom incidence and duration were evaluated in healthy children during the winter season.
Methods:
In this double-blind, placebo-controlled study, 326 eligible children (3-5 years of age) were assigned randomly to receive placebo (N = 104), Lactobacillus acidophilus NCFM (N = 110), or L acidophilus NCFM in combination with Bifidobacterium animalis subsp lactis Bi-07 (N = 112). Children were treated twice daily for 6 months.
Results:
Relative to the placebo group, single and combination probiotics reduced fever incidence by 53.0% (P = .0085) and 72.7% (P = .0009), coughing incidence by 41.4% (P = .027) and 62.1% (P = .005), and rhinorrhea incidence by 28.2% (P = .68) and 58.8% (P = .03), respectively. Fever, coughing, and rhinorrhea duration was decreased significantly, relative to placebo, by 32% (single strain; P = .0023) and 48% (strain combination; P < .001). Antibiotic use incidence was reduced, relative to placebo, by 68.4% (single strain; P = .0002) and 84.2% (strain combination; P < .0001). Subjects receiving probiotic products had significant reductions in days absent from group child care, by 31.8% (single strain; P = .002) and 27.7% (strain combination; P < .001), compared with subjects receiving placebo treatment.
Conclusion:
Daily dietary probiotic supplementation for 6 months was a safe effective way to reduce fever, rhinorrhea, and cough incidence and duration and antibiotic prescription incidence, as well as the number of missed school days attributable to illness, for children 3 to 5 years of age.
Related Concept Videos
Probiotics
Vaccinations
Development of Human Microbiota
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
Microbiota Modulation by Antibiotics
Respiratory Syncytial Virus Disease